(Q66038982)

English

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Study of Doxorubicin Hydrochloride Adsorbed to Magnetic Targeted Carriers (MTC-DOX) Administered by Intrahepatic Delivery Versus Intravenous Doxorubicin for Treatment of Patients With Unresectable Hepatocellular Carcinoma (English)

0 references

0 references

0 references

0 references

0 references

0 references

0 references

United States of America

0 references

located in the administrative territorial entity

Hong Kong

0 references

start time

March 2002

0 references

number of participants

240

0 references

research intervention

doxorubicin

0 references

Caelyx

0 references

clinical trial phase

phase II clinical trial

0 references

phase III clinical trial

0 references

research site

Cornell University

0 references

Cleveland Clinic

0 references

University of Cologne

0 references

University of Hong Kong

0 references

The Queen Elizabeth Hospital

0 references

Royal Infirmary of Edinburgh

0 references

minimum age

18 year

0 references

maximum age

80 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00034333

0 references

(Q66038982)

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)